A Q&A with Matt Hawkins, Co-Founder & Managing Partner at Entourage Effect Capital

In this article, Aaron Green sits down with Matt Hawkins, Co-Founder and Managing Partner at Entourage Effect Capital to learn more about his investment philosophy and get his perspective on recent trends in the cannabis industry.

The post A Q&A with Matt Hawkins, Co-Founder & Managing Partner at Entourage Effect Capital appeared first on Cannabis Industry Journal.

Cannabis Revival and Year of the SPAC’s: What’s To Be Expected the Rest of 2021?

The rise of the SPAC-era and Canadian entry into the U.S. market will cause asset increases, but it is only the second chapter in the market expansion of cannabis.

The post Cannabis Revival and Year of the SPAC’s: What’s To Be Expected the Rest of 2021? appeared first on Cannabis Industry Journal.

Jazz Pharmaceuticals to Acquire GW Pharma

In a press release published last week, the two companies announced they have entered an agreement for Jazz to acquire GW Pharma, the producer of the only FDA-approved CBD medication Epidiolex, for a total of $7.2 billion.

The post Jazz Pharmaceuticals to Acquire GW Pharma appeared first on Cannabis Industry Journal.

Cresco Labs Acquires Bluma Wellness

Cresco Labs will enter the Florida market with the acquisition of Bluma Wellness (and its subsidiary One Plant Florida) for an equity value of $213 million, expected to be finalized by the second quarter of this year.

The post Cresco Labs Acquires Bluma Wellness appeared first on Cannabis Industry Journal.

Cannabis M&A in the Post-COVID Era

Prospects for the New Year are expected to continue the explosive year-end trend with a backlog of nearly $2 billion in deals heading into 2021. Growth is expected to be led by multi-state operators who have achieved scale, cleaned up their balance sheets and stockpiled dry powder for roll-up acquisitions.

The post Cannabis M&A in the Post-COVID Era appeared first on Cannabis Industry Journal.